By successfully encapsulating a vaccine into a spider silk microparticle, Swiss and German researchers have discovered a novel technique that will help fight cancer and certain infectious diseases.
To fight cancer, researchers increasingly use vaccines that stimulate the immune system to identify and destroy tumour cells. However, the desired immune response is is not always guaranteed. In order to strengthen the efficacy of vaccines on the immune system – and in particular on T lymphocytes, specialized in the detection of cancer cells – researchers from the universities of Geneva (UNIGE), Freiburg (UNIFR), Munich, and Bayreuth, in collaboration with the German company AMSilk, have developed spider silk microcapsules capable of delivering the vaccine directly to the heart of immune cells. This process, published in the journal Biomaterials, could also be applied to preventive vaccines to protect against infectious diseases, and constitutes an important step towards vaccines that are stable, easy to use, and resistant to the most extreme storage conditions.
Our immune system is largely based on two types of cells: B lymphocytes, which produce the antibodies needed to defend against various infections, and T lymphocytes. In the case of cancer and certain infectious diseases such as tuberculosis, T lymphocytes need to be stimulated. However, their activation mechanism is more complex than that of B lymphocytes: to trigger a response, it is necessary to use a peptide, a small piece of protein which, if injected alone, is rapidly degraded by the body even before reaching its target.
“To develop immunotherapeutic drugs effective against cancer, it is essential to generate a significant response of T lymphocytes,» says Professor Carole Bourquin, a specialist in antitumor immunotherapies at the faculties of medicine and science of the UNIGE, who directed this work. “As the current vaccines have only limited action on T-cells, it is crucial to develop other vaccination procedures to overcome this issue.”
A virtually indestructible capsule
Scientists used synthetic spider silk biopolymers—a lightweight, biocompatible, non-toxic material that is highly resistant to degradation from light and heat. “We recreated this special silk in the lab to insert a peptide with vaccine properties,» explains Thomas Scheibel, a world specialist of spider silk from the University of Bayreuth who participated in the study. “The resulting protein chains are then salted out to form injectable microparticles.”
Silk microparticles form a transport capsule that protects the vaccine peptide from rapid degradation in the body, and delivers the peptide to the center of the lymph node cells, thereby considerably increasing T lymphocyte immune responses. “Our study has proved the validity of our technique”, reveals Carole Bourquin. “We have demonstrated the effectiveness of a new vaccination strategy that is extremely stable, easy to manufacture and easily customizable.”
Towards a new vaccine model
The synthetic silk biopolymer particles demonstrate a high resistance to heat, withstanding over 100°C for several hours without damage. In theory, this process would make it possible to develop vaccines that do not require adjuvants and cold chains. An undeniable advantage, especially in developing countries where one of the great difficulties is the preservation of vaccines. One of the limitations of this process, however, is the size of the microparticles: while the concept is in principle applicable to any peptide, which are all small enough to be incorporated into silk proteins, further research is needed to see if it is also possible to incorporate the larger antigens used in standard vaccines, especially against viral diseases.
When science imitates nature
“More and more, scientists are trying to imitate nature in what it does best”, adds Scheibel. “This approach even has a name: bioinspiration, which is exactly what we have done here.” The properties of spider silk make it a particularly interesting product: biocompatible, solid, thin, biodegradable, resistant to extreme conditions and even antibacterial, one can imagine multiple applications, including wound dressings or sutures.
Learn more: A new kind of vaccine based on spider silk
The Latest on: Vaccine delivery
[google_news title=”” keyword=”vaccine delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Vaccine delivery
- Covid infections led to spike in preterm births, vaccines helped decrease it: Studyon December 1, 2023 at 12:36 pm
An alarming increase in premature births was attributed to Covid-19, but researchers, analysing birth records in California, US, have found that vaccines played a crucial role in restoring the ...
- Simple-to-apply, needle-free vaccine patch developed against Zika infectionon December 1, 2023 at 9:14 am
The vaccine, described in the journal Molecular Therapy Nucleic Acids, uses the high-density microarray patch (HD-MAP) patch developed by the University of Queensland (UQ) in Australia for delivery.
- Needle-free vaccine patch offers protection against Zika virus in preclinical trialon December 1, 2023 at 4:03 am
A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.
- Kenya spearheads malaria vaccine triumphon November 30, 2023 at 10:57 pm
Malaria burden is the highest on the African continent, which accounts for approximately 95% of global malaria cases and 96 percent of related deaths in 2021.
- New needle-free vaccine patch to protect against Zika viruson November 30, 2023 at 4:00 pm
The vaccine patch also evoked T-cell responses that were about 270 per cent higher than from a needle or syringe vaccine delivery, the researchers said. Dr David Muller from University of Queensland’s ...
- Unions calling on government to stop using private health care provider for vaccine clinicon November 30, 2023 at 11:00 am
The Registered Nurses’ Union Newfoundland & Labrador is concerned about what it calls a disconnect between the words of the Premier and the actions of the government he leads. “Once again the promises ...
- Needle-free vaccine patch can protect people from deadly Zika viruson November 29, 2023 at 3:59 pm
The vaccine patch evoked T-cell responses that were about 270 per cent higher than from a needle or syringe vaccine delivery." Dr Danushka Wijesundara, UQ alum and Vaxxas researcher Zika virus ...
- 20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Programon November 29, 2023 at 12:00 am
Hugo_Fry_by_Barry_Braunstein_Photography Hugo Fry, Chief Business Officer, 20Med Therapeutics Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA ...
- 1 Pharma Stock to Buy on Strong Vaccine Growth Potentialon November 28, 2023 at 1:48 pm
In view of this strong performance, GSK raised its guidance for 2023. The company now expects turnover to increase from 12% to 13%, up from the previously announced 8% to 10%. It also now anticipates ...
via Bing News